Jurgi  Camblong net worth and biography

Jurgi Camblong Biography and Net Worth

Founder and CEO of SOPHiA GENETICS

Dr. Jurgi Camblong, Ph.D., M.B.A., is a visionary entrepreneur who is pioneering the data-driven medicine movement around the world.

In 2011, he founded SOPHiA GENETICS with Dr. Pierre Hutter and Prof. Lars Steinmetz and has successfully led the development of the company as CEO ever since. Jurgi was a member of the Advisory Council on Digital Transformation to the Swiss Government, is a board member of the Swiss Biotech Association and was personally recognized by EY as Emergent Entrepreneur of the Year in 2017, listed among the 50 Smartest Companies by the MIT Technology Review. Jurgi has been a member of the board of directors since March 2011.

He is a molecular biologist (published in Cell, Science and Nature), has a Ph.D. in life sciences from the University of Geneva and an Executive M.B.A. in management of technology from EPFL/HEC Lausanne.

What is Jurgi Camblong's net worth?

The estimated net worth of Jurgi Camblong is at least $19.21 million as of April 20th, 2026. Dr. Camblong owns 3,642,481 shares of SOPHiA GENETICS stock worth more than $19,214,087 as of May 1st. This net worth estimate does not reflect any other assets that Dr. Camblong may own. Learn More about Jurgi Camblong's net worth.

How do I contact Jurgi Camblong?

The corporate mailing address for Dr. Camblong and other SOPHiA GENETICS executives is , , . SOPHiA GENETICS can also be reached via phone at 41-21-694-1060. Learn More on Jurgi Camblong's contact information.

Has Jurgi Camblong been buying or selling shares of SOPHiA GENETICS?

Over the course of the past ninety days, Jurgi Camblong has sold $450,886.18 of SOPHiA GENETICS stock. Most recently, Jurgi Camblong sold 4,486 shares of the business's stock in a transaction on Monday, April 20th. The shares were sold at an average price of $5.21, for a transaction totalling $23,372.06. Following the completion of the sale, the chief executive officer now directly owns 3,642,481 shares of the company's stock, valued at $18,977,326.01. Learn More on Jurgi Camblong's trading history.

Who are SOPHiA GENETICS's active insiders?

SOPHiA GENETICS's insider roster includes Jurgi Camblong (Founder and CEO), George Cardoza (EVP – Chief Financial Officer), Philippe Menu (Insider), Kevin Puylaert (SVP, Chief Sales Officer), and Abhimanyu Verma (EVP, Chief Technology Officer). Learn More on SOPHiA GENETICS's active insiders.

Are insiders buying or selling shares of SOPHiA GENETICS?

In the last twelve months, insiders at the sold shares 57 times. They sold a total of 193,859 shares worth more than $943,777.03. The most recent insider tranaction occured on April, 27th when insider Philippe Menu sold 5,000 shares worth more than $24,100.00. Insiders at SOPHiA GENETICS own 4.9% of the company. Learn More about insider trades at SOPHiA GENETICS.

Information on this page was last updated on 4/27/2026.

Jurgi Camblong Insider Trading History at SOPHiA GENETICS

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/20/2026Sell4,486$5.21$23,372.063,642,481View SEC Filing Icon  
4/15/2026Sell17,473$5.00$87,365.003,646,967View SEC Filing Icon  
4/14/2026Sell43,129$4.96$213,919.843,664,440View SEC Filing Icon  
4/13/2026Sell4,399$4.76$20,939.243,707,569View SEC Filing Icon  
4/10/2026Sell12,232$4.72$57,735.043,711,968View SEC Filing Icon  
4/9/2026Sell1,950$4.74$9,243.003,724,200View SEC Filing Icon  
4/8/2026Sell2,800$4.84$13,552.003,726,150View SEC Filing Icon  
4/7/2026Sell2,500$4.86$12,150.003,728,950View SEC Filing Icon  
4/6/2026Sell2,600$4.85$12,610.003,731,450View SEC Filing Icon  
3/19/2026Sell4,486$4.77$21,398.223,302,839View SEC Filing Icon  
See Full Table

Jurgi Camblong Buying and Selling Activity at SOPHiA GENETICS

This chart shows Jurgi Camblong's buying and selling at SOPHiA GENETICS by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

SOPHiA GENETICS Company Overview

SOPHiA GENETICS logo
SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Rolle, Switzerland.
Read More

Today's Range

Now: $5.32
Low: $5.23
High: $5.37

50 Day Range

MA: $4.81
Low: $4.10
High: $5.28

2 Week Range

Now: $5.32
Low: $2.59
High: $5.70

Volume

51,479 shs

Average Volume

169,220 shs

Market Capitalization

$364.37 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.04